These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3126841)

  • 21. Microporous, complaint, biodegradable vascular grafts for the regeneration of the arterial wall in rat abdominal aorta.
    van der Lei B; Bartels HL; Nieuwenhuis P; Wildevuur CR
    Surgery; 1985 Nov; 98(5):955-63. PubMed ID: 4060072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor.
    Athanasiou KA; Singhal AR; Agrawal CM; Boyan BD
    Clin Orthop Relat Res; 1995 Jun; (315):272-81. PubMed ID: 7634681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo characteristics of low molecular weight copolymers composed of L-lactic acid and various DL-hydroxy acids as biodegradable carriers for drug delivery systems.
    Fukuzaki H; Yoshida M; Asano M; Kumakura M; Mashimo T; Yuasa H; Imai K; Yamanaka H
    Biomaterials; 1990 Aug; 11(6):441-6. PubMed ID: 2207236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilized polyglycolic acid fibre-based tubes for tissue engineering.
    Mooney DJ; Mazzoni CL; Breuer C; McNamara K; Hern D; Vacanti JP; Langer R
    Biomaterials; 1996 Jan; 17(2):115-24. PubMed ID: 8624388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs.
    Ma G; Song C; Sun H; Yang J; Leng X
    Contraception; 2006 Aug; 74(2):141-7. PubMed ID: 16860052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of the pro-inflammatory response by tetrandrine-loading poly(L-lactic acid) films in vitro and in vivo.
    Wang QS; Cui YL; Gao LN; Guo Y; Li RX; Zhang XZ
    J Biomed Mater Res A; 2014 Nov; 102(11):4098-107. PubMed ID: 24442958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The preparation of poly (DL-lactide) hollow fiber and the release of drug in vitro].
    Zhu J; Shen Z; Ma Z; Wu L; Shi D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Sep; 14(3):247-51. PubMed ID: 11326842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of levonorgestrel after a single dose of biodegradable microspheres containing levonorgestrel in rats].
    Zhang LC; Sang GW; Shao QX
    Yao Xue Xue Bao; 1994; 29(8):561-5. PubMed ID: 7985513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release.
    von Recum HA; Cleek RL; Eskin SG; Mikos AG
    Biomaterials; 1995 Apr; 16(6):441-7. PubMed ID: 7654870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility study of as-polymerized poly(L-lactide) in rats using a cage implant system.
    Bergsma JE; Rozema FR; Bos RR; Boering G; de Bruijn WC; Pennings AJ
    J Biomed Mater Res; 1995 Feb; 29(2):173-9. PubMed ID: 7738063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reinforced poly(L-lactic acid) fibres as suture material.
    Lam KH; Nijenhuis AJ; Bartels H; Postema AR; Jonkman MF; Pennings AJ; Nieuwenhuis P
    J Appl Biomater; 1995; 6(3):191-7. PubMed ID: 7492810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid).
    Andreopoulos AG
    J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical and biodegradable properties of porous titanium filled with poly-L-lactic acid by modified in situ polymerization technique.
    Nakai M; Niinomi M; Ishii D
    J Mech Behav Biomed Mater; 2011 Oct; 4(7):1206-18. PubMed ID: 21783129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability.
    Lam KH; Schakenraad JM; Esselbrugge H; Feijen J; Nieuwenhuis P
    J Biomed Mater Res; 1993 Dec; 27(12):1569-77. PubMed ID: 8113245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of Porous Core-Shell Poly L-Lactic Acid/Polyethylene Glycol Superfine Fibres Containing Drug.
    Yang W; He N; Fu J; Li Z; Ji X
    J Nanosci Nanotechnol; 2015 Dec; 15(12):9911-7. PubMed ID: 26682434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo release of a GnRH agonist from a slow-release poly(lactide-glycolide) copolymer preparation: comparison in rat, rabbit and guinea-pig.
    Heinrich N; Fechner K; Berger H; Lorenz D; Albrecht E; Rafler G; Schäfer H; Mehlis B
    J Pharm Pharmacol; 1991 Nov; 43(11):762-5. PubMed ID: 1686903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fabrication, characterization and drug release characteristics of drug loaded poly (L-lactic acid) fiber].
    Gao H; Ping Q; Gu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):870-3. PubMed ID: 18788299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.